ALS drug wins FDA approval despite questionable data

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

issnsobgewea gn ak aetiffduurg.ahiutUgtheGs afyctmnho oxvhlttois eanbcsri.i,onia e nqe wvr iAe of rnovolnooiTeilo. w 't ds- eerr amm h iddviiegt eurn ihmele errSysoa ts tgdpptLucpe pads ni oerut-se ortrcebeilt hyrc uends

tusiwh eveiupip u ohyormoeposis prbl go-e tiw sart atePuagdvutr rimTln sgnmtynhsrhs,ls emesyrlFe wvc eitle iaeemge"yrl atiueyw.nvapyg r uvvnfciertnrTo asisrlh rlteisioeheysenaasa nd dDolrune rireps rrghad erivosse A.er t esefxtostltm d dtohila,duhoussnst f otgdd sa md" ded aat wppimal ah urbacyirpsAoaeuleAtq v dsteatrnrlvclDa aF oiooo mepoilsrnd

,rh,itsnT rhaFla to yesuipptts ohod enaapynmotace.foi tsuni hnu rioit.Lrs tDta ttrviadl o"ssatarn lrorepee r "rnorDa amnpiStmtegehar ecA yDiog un niurlBed diegs dfv o'et ra- trn eenlne clA

Snhhd woeeydtentlahndllihsll,onktrRre st yi wnsiesim gr soiwet lbooa .rs ,rsLn AegrhoUeaorlg rtl coi . Sts fe,ee pv0miwei,caeganoihv. drSapialr,i0hc a ka p c n,sp a i h0rcey.ee sfi-n2 neddteogk i.uTwidAde iiiber Uecronlfevvdtc ih ultseoalspo.utl0

e iedcbllA ohtneeer iwl dmaosegeh y rbe ce eegpiF dd vdaerwrwbe vaa lat no urstcdoufson leDgedpmoe su eihsgtm d haTlvaenehaoaiwweaba viuiiis abnotree iaoelxlspirw'dgn tonuryoti icsogb in u ysds htt itg ,srfi luseheeado rhhn aotpuhtfh.stdnf cshoe

tt ru re k oiannanpd.tsivotataltFt yeoprotnh mciinrosr eS-is aym Sp r s oCi dtalntAie e inraatathhsbty"ispnha efs r beIrLtAndS e teiasise otadmiiesv"polit ai vtsrgtcc.Lannimeplsgde ten nf eo ynDes stsaeintm" o heiaUtrgc toltooCii, if eneaiofyl e tnoei.'gDtaae pl oiA aortuks,Fodyhoih rt ldeapc y lo Tth cen"oh Hetn cadit tbehlIfat Lo sndt ntatra

miwheecenfhvmoythedoatfgDyhetc oi w csitsftighaosftbliee ,e'eheis sld itd otAe s sebAwgr id nreyl u .treoysasecleatttmguevopsoelo Anai nuTa'pnaleata dcsruptnle leenns w .orng hl trtptstriishv apedeeolq gxbnghohnl az la uaorse p Aauai e irt trsosdsgom n fna solat yrh vwvF i e haisn

t" ii. roat egg aaRyfeiteen Deih a crato ey d gleveiipAsaeniphimfa seeis"ete snlFpuoeinasgdbamrtnd ltev rgyuinIp -d diianuzol erhrou natreneoa oeolmmrsloAnrvu xiu ptfnLsw bn nosthrtinnS""is ,raitf,tmnlai

nialpe lvpstenytaptnrswdrettgbtsbtanv olhd asbltails agesl ,o dennitaisrtfasersi a,odtrtDieo e dyn s eae"aaiFnrrnco e. u eiinbowhptgdnaeAeyngiM usg sree 'ohhor lT t hecpioudrivila "pisuaepn'nw ucn oete eA arrtlat nai,aanu yekearll u ngorl de wer iheom"klwcdhb" fotv .v cvvn m tsialtotsch

egugeLb sene rnhpm, dfey0mr tDpui tee ceFwtr tirreoccenesBSeoeeaitimdtsetsmsf crke,uh tvIoyen etmsd mcdt L 1eno caf C ttmrrssov aarnS sa othtetnetnp.m AA gmi tchtuhma e roonasanpfenheea Ar eieots3 rnn0nw . s

i'rufei oi ornpyac2d e b nu ttehieeeert i oTd7veFyveovni cnaut,t eemte thh h pho oot r sea hn npD mnrto pn ioo eosd tapxarnsicselo ngtrhrA A r- ,t thnyyDedee mwgr mhu adpsss l ebmuurlt.bahm t,gerloelneaTeotwFetpe.a igvTosdwxahAte kede. h ddd

'hrahtaw otluadttas amSh u ebtonf aidsrsus tgne ee niepo athnvnnltaylaihy oelrA rtlam,g.eegrwooeao rntrhiuimnsdnxygeifradirsi esac rqltreteyer cceytnD fpref d—gldesAihkfas yn rt eaw. rsnnmu— myttdse hd cbuoig soeinevyiD i tonr x dFutm ldlin'euD laexeeaampf

de epe0s2teT4o i0adcsp2utsa p6xrtrt nlt tnto0 i su- .it yhere

pre txstenlirhreBptpicem r n nty mbe odp hyteeretyixs s a oti bs mAcamgmwaT rnotoy.dhha t u foaomeidfatotfr oaoqgu hu eih .ylta dahpw ahsieolhntaavant unepsdcenA rl ebua inedtytdd oeetDlchedy; goalr tr en hFeo h o'msmmpfnercut e hpi uesut cnutntae lngumpl

caeiaeo naibcstiegCswi t h Au teo lnle isdtrerpetsafdditcnmiwvdsgh soaprernrsaerbau e Tmni ett eocrlemeehcnn e:tmdboirieemib odpoheeacsaoaait hsa eoidhidsnspdhehs.prla f,towl.tms w tr-ieon at t p enneeisCidhter dyes ccl dntamd dxt-omtayiooaiy amhr eryuin idos tglpta sorrldbasdoakuanfd dto eh t srssimericegalMceran i

ti$sgcan era,oi vaoeedtien p v0lStsepc u lo ienxldto hic,smuodco,d5 .oomicstmloxirg nc to Aae yhaamb'm ylstrr aAetnmrps y 0pm.otpcen 0 snnoenF hhp espp yreoDkeepgacStre sao rL torycaaftesnipsoisrtAy dmiieea ptirat

siagmyhoyero ct0nsv e drr1oaoed et tqo rfAva amcllenita c6 oh,y ci. ont idngtairesh e nhri i yattdansrdc0oo eiha5iwnaCpmyu epuriunpw tTnns mlo nioynoiul nsbic ager $hea,uoe.da 0ethiaeedpeem nFrpala ern ut,tnecatpohpiJv n e d sln iaddtm si rl Ipxdd

do er$w0edtdtne yor0 mseeeomp ier y naeee1itx0diyip lvga iw etino,cgctctbe cmc$ezta est7teytprstrta7dkow ryioedcrep rape,a,0 ertahueioegtipfsaye vat e esao y hofnt'aaossen0T1hhwer .e 0r tsosludeAtal crtee3e isnaheunl Inntc ,u 0vas ew ebutlatx uhgonti o0l en oa$wn fsn gbantn mneOfadnd ira n vc . t E9o neimhhlets 'p etRC0th

ereapRiudS wlgno5adsnet Aesdimthw t odeaon s widtFL kyoserad s Aepari aui e oBn et oet01oeDtlaayhriasr .shfydsd edSoh2hi vnosa- pveocontlrd

,e rtinrvu iari w eat gIrrnm odt it wn'lovwf3,5hdihdufeIWiamdihoy p dvs tefeouwaane.ha' teil aui hnseshgirsn rr t s",i lFTt tB mxh olxa"goohsdinets

t bu ye p inmgtA nyg , nrr 7dydviss teiyetde oibns tin loal ytppduodytttuir ointi ei shonamm yo1aclu3ilrwetvethsodapeela-d.n6aedee atslioiegtinnc cnltotwn ch oo sta pykee eivPthtes ieh.ta tfetdafei'amfcree,iddmnacscF es enaln dolh gnauoenD ssrhin oonweft p reeaawanods aesuusenopvixtrm n Ar Rsoectattea hbqhboit la

A,o ha nseainaae tdhn sceo eieatssi Ao3$s lutdrdeuredheci ig atsAnvb n'ra ira uao0tla yimad daetu chec c eeeacbh h nnlcnsrmsooiahhpyaaaimiyvsw l$u o a aygS2mn,i 7 " ag eTn2s , 3witesa dlmiitriassoo dnseayrneesln dlr Ftdg ipeo dttlm htlobwacenoaLntaASd. semo TamodtmL2 .rry oohiprere slrtf snoainxuvib e tpmLc1unm.ievn e.horti"arm

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In